186 related articles for article (PubMed ID: 31347928)
1. Efficacy of Hybrid Closed-Loop System in Adults with Type 1 Diabetes and Gastroparesis.
Kaur H; Schneider N; Pyle L; Campbell K; Akturk HK; Shah VN
Diabetes Technol Ther; 2019 Dec; 21(12):736-739. PubMed ID: 31347928
[TBL] [Abstract][Full Text] [Related]
2. Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.
Daly A; Hartnell S; Boughton CK; Evans M
J Diabetes Sci Technol; 2021 Nov; 15(6):1216-1223. PubMed ID: 34378426
[TBL] [Abstract][Full Text] [Related]
3. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the usage of an open-source automated insulin delivery system and the MiniMed™ 780 G system in children and adolescents with type 1 diabetes in real-world settings: the AWeSoMe study group.
Landau Z; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Jacobi-Polishook T; Ben Ari T; Abiri S; Haim A; Nir J; Rachmiel M; Pinhas-Hamiel O
Endocrine; 2024 Jun; 84(3):943-950. PubMed ID: 38225516
[TBL] [Abstract][Full Text] [Related]
5. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
[TBL] [Abstract][Full Text] [Related]
6. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.
Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN
Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889
[No Abstract] [Full Text] [Related]
7. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
8. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Garg SK; Weinzimer SA; Tamborlane WV; Buckingham BA; Bode BW; Bailey TS; Brazg RL; Ilany J; Slover RH; Anderson SM; Bergenstal RM; Grosman B; Roy A; Cordero TL; Shin J; Lee SW; Kaufman FR
Diabetes Technol Ther; 2017 Mar; 19(3):155-163. PubMed ID: 28134564
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
[TBL] [Abstract][Full Text] [Related]
10. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
[No Abstract] [Full Text] [Related]
11. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
[TBL] [Abstract][Full Text] [Related]
13. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
Jendle J; Pöhlmann J; de Portu S; Smith-Palmer J; Roze S
Diabetes Technol Ther; 2019 Mar; 21(3):110-118. PubMed ID: 30785311
[TBL] [Abstract][Full Text] [Related]
15. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
[TBL] [Abstract][Full Text] [Related]
16. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
Galderisi A; Sherr JL
Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
[TBL] [Abstract][Full Text] [Related]
17. Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: A case series.
Phan F; Halbron M; Jacqueminet S; Popelier M; Soliman H; Coffin B; Hartemann A; Amouyal C
Diabetes Metab; 2023 Sep; 49(5):101471. PubMed ID: 37657737
[No Abstract] [Full Text] [Related]
18. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
Lepore G; Rossini A; Bellante R; Corsi A; Scaranna C; Dodesini AR; Trevisan R
Acta Diabetol; 2022 Oct; 59(10):1309-1315. PubMed ID: 35857108
[TBL] [Abstract][Full Text] [Related]
19. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
Rodbard D
Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
